{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:52:09Z","timestamp":1790376729434,"version":"4.1.0"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"abstract":"<jats:p>OBJECTIVE. Newborn screening for cystic fibrosis was introduced in the Piedmont region of Italy in the year 2000. Our aim with this study was to estimate the effect of newborn screening on the risk of Pseudomonas aeruginosa infection at the regional cystic fibrosis pediatric reference center.<\/jats:p><jats:p>METHODS. The time to first infection with P aeruginosa within the historical cohort of cystic fibrosis children diagnosed between January 1, 1997, and June 30, 2004, was investigated, comparing survival functions and the adjusted hazard ratio of children diagnosed before and after newborn screening introduction. The role of pancreatic insufficiency was also concurrently investigated.<\/jats:p><jats:p>RESULTS. Overall, 71 children diagnosed with cystic fibrosis were identified, 27 cases were clinically diagnosed before newborn screening introduction, and 5 of them presented with meconium ileus, whereas 44 were identified by newborn screening. Among them 35 needed pancreatic enzyme supplementation, whereas 34 children were infected with P aeruginosa. Both the nonparametric and semiparametric survival estimates failed to show any significant increase in the risk of P aeruginosa infection among screened children compared with historical controls. However, the median time from cystic fibrosis diagnosis to P aeruginosa infection among screened children was significantly shorter (183 vs 448 days). Children with impaired pancreatic function were at high risk of P aeruginosa infection.<\/jats:p><jats:p>CONCLUSIONS. The results of the study suggest that health authorities should regard newborn screening for cystic fibrosis as an opportunity to improve care and outcomes among affected children and shift the focus from whether it is appropriate to screen to how to optimize biomedical and psychosocial outcomes of screening.<\/jats:p>","DOI":"10.1542\/peds.2004-2599","type":"journal-article","created":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T21:17:38Z","timestamp":1157145458000},"page":"888-895","source":"Crossref","is-referenced-by-count":19,"title":["Neonatal Screening for Cystic Fibrosis Does Not Affect Time to First Infection With<i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1542","volume":"118","author":[{"given":"Iacopo","family":"Baussano","sequence":"first","affiliation":[{"name":"Cancer Epidemiology Unit, CPO Piemonte, CeRMS, University of Turin, Turin, Italy"},{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Tardivo","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Bellezza-Fontana","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Forneris","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Lezo","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Anfossi","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Castello","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veljkovic","family":"Aleksandar","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bignamini","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Regional Reference Unit, ASO OIRM-Sant\u2019Anna, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"2021120822525053400_R1","doi-asserted-by":"crossref","unstructured":"Wildhagen MF, Kate LP, Habbema JD. Screening for cystic fibrosis and its evaluation. Br Med Bull.\u20081998;54:857\u2013875","DOI":"10.1093\/oxfordjournals.bmb.a011734"},{"key":"2021120822525053400_R2","doi-asserted-by":"crossref","unstructured":"Wald NJ, Morris JK. Neonatal screening for cystic fibrosis. BMJ.\u20081998;316:404\u2013405","DOI":"10.1136\/bmj.316.7129.404"},{"key":"2021120822525053400_R3","doi-asserted-by":"crossref","unstructured":"Dankert-Roelse JE, Meerman GJ. Screening for cystic fibrosis: time to change our position?N Engl J Med.\u20081997;337:997\u2013999","DOI":"10.1056\/NEJM199710023371409"},{"key":"2021120822525053400_R4","unstructured":"American Society of Human Genetics, Ad Hoc Committee on Cystic Fibrosis Carrier Screening. Statement of the American Society of Human Genetics on cystic fibrosis carrier screening. Am J Hum Genet.\u20081992;51:1443\u20131444"},{"key":"2021120822525053400_R5","unstructured":"Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development\u2014proceedings of a 1997 workshop. MMWR Recomm Rep.\u20081997;46(RR-16):1\u201324"},{"key":"2021120822525053400_R6","doi-asserted-by":"crossref","unstructured":"Farrell PM. Cystic fibrosis newborn screening: shifting the key question from \u201cshould we screen?\u201d to \u201chow should we screen?\u201d Pediatrics.\u20082004;113:1811\u20131812","DOI":"10.1542\/peds.113.6.1811"},{"key":"2021120822525053400_R7","unstructured":"Grosse SD, Boyle CA, Botkin JR, et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep.\u20082004;53(RR-13):1\u201336"},{"key":"2021120822525053400_R8","doi-asserted-by":"crossref","unstructured":"Dankert-Roelse JE, Merelle ME. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr.\u20082005;147:S15\u2013S20","DOI":"10.1016\/j.jpeds.2005.08.009"},{"key":"2021120822525053400_R9","doi-asserted-by":"crossref","unstructured":"Farrell PM, Lai HJ, Li Z, et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!J Pediatr.\u20082005;147:S30\u2013S36","DOI":"10.1016\/j.jpeds.2005.08.012"},{"key":"2021120822525053400_R10","doi-asserted-by":"crossref","unstructured":"Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J Pediatr.\u20082005;147:S11\u2013S14","DOI":"10.1016\/j.jpeds.2005.08.010"},{"key":"2021120822525053400_R11","doi-asserted-by":"crossref","unstructured":"Koscik RL, Douglas JA, Zaremba K, et al. Quality of life of children with cystic fibrosis. J Pediatr.\u20082005;147:S64\u2013S68","DOI":"10.1016\/j.jpeds.2005.09.001"},{"key":"2021120822525053400_R12","doi-asserted-by":"crossref","unstructured":"Vonberg RP, Gastmeier P. Isolation of infectious cystic fibrosis patients: results of a systematic review. Infect Control Hosp Epidemiol.\u20082005;26:401\u2013409","DOI":"10.1086\/502558"},{"key":"2021120822525053400_R13","doi-asserted-by":"crossref","unstructured":"Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol.\u20082001;32:277\u2013287","DOI":"10.1002\/ppul.2009.abs"},{"key":"2021120822525053400_R14","doi-asserted-by":"crossref","unstructured":"Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol.\u20081997;23:330\u2013335","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O"},{"key":"2021120822525053400_R15","doi-asserted-by":"crossref","unstructured":"Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol.\u20082002;34:91\u2013100","DOI":"10.1002\/ppul.10127"},{"key":"2021120822525053400_R16","doi-asserted-by":"crossref","unstructured":"Merelle ME, Nagelkerke AF, Lees CM, Dezateux C. Newborn screening for cystic fibrosis. Cochrane Database Syst Rev.\u20082001;(3):CD001402","DOI":"10.1002\/14651858.CD001402"},{"key":"2021120822525053400_R17","doi-asserted-by":"crossref","unstructured":"Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol.\u20081998;26:81\u201388","DOI":"10.1002\/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K"},{"key":"2021120822525053400_R18","doi-asserted-by":"crossref","unstructured":"Sims EJ, McCormick J, Mehta G, Mehta A. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment. J Pediatr.\u20082005;147:S42\u2013S46","DOI":"10.1016\/j.jpeds.2005.08.002"},{"key":"2021120822525053400_R19","unstructured":"Bossi A, Battistini F, Braggion C, et al. Italian Cystic Fibrosis Registry: 10 years of activity [in Italian]. Epidemiol Prev.\u20081999;23:5\u201316"},{"key":"2021120822525053400_R20","unstructured":"Padoan R, Pardo F, Giglio L, Bossi A. Regional differences in the incidence of cystic fibrosis in Italy. Ital J Pediatr.\u20082001;27:876\u2013886"},{"key":"2021120822525053400_R21","unstructured":"Deliberazione della Giunta Regionale, No. 36-9747. Bollettino Ufficiale Torino, Italy, June 26, 2003"},{"key":"2021120822525053400_R22","unstructured":"Decreto Del Presidente Del Consiglio Dei Ministri. Population of the Italian republic according to the national census, 21st October 2001 [in Italian]. Gazzetta Ufficiale Serie Generale\u20082003; No. 81"},{"key":"2021120822525053400_R23","doi-asserted-by":"crossref","unstructured":"Tomaiuolo R, Spina M, Castaldo G. Molecular diagnosis of cystic fibrosis: comparison of four analytical procedures. Clin Chem Lab Med.\u20082003;41:26\u201332","DOI":"10.1515\/CCLM.2003.006"},{"key":"2021120822525053400_R24","doi-asserted-by":"crossref","unstructured":"Bull K, Spiegelhalter DJ. Survival analysis in observational studies. Stat Med.\u20081997;16:1041\u20131074","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<1041::AID-SIM506>3.0.CO;2-F"},{"key":"2021120822525053400_R25","doi-asserted-by":"crossref","unstructured":"Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol.\u20082003;35:257\u2013262","DOI":"10.1002\/ppul.10230"},{"key":"2021120822525053400_R26","doi-asserted-by":"crossref","unstructured":"Boyton RJ, Openshaw PJ. Pulmonary defences to acute respiratory infection. Br Med Bull.\u20082002;61:1\u201312","DOI":"10.1093\/bmb\/61.1.1"},{"key":"2021120822525053400_R27","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics. NBS Task Force. Newborn screening: a blueprint for the future executive summary: newborn screening task force report. Pediatrics.\u20082000;106:386\u2013388","DOI":"10.1542\/peds.106.S2.386"},{"key":"2021120822525053400_R28","doi-asserted-by":"crossref","unstructured":"Farrell PM, Shen G, Splaingard M, et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics.\u20081997;100(2). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/2\/e2","DOI":"10.1542\/peds.100.5.e2"},{"key":"2021120822525053400_R29","doi-asserted-by":"crossref","unstructured":"Wang SS, FitzSimmons SC, O'Leary LA, Rock MJ, Gwinn ML, Khoury MJ. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: a registry-based longitudinal study. Pediatrics.\u20082001;107:274\u2013279","DOI":"10.1542\/peds.107.2.274"},{"key":"2021120822525053400_R30","doi-asserted-by":"crossref","unstructured":"Egger M, George DS, O'Rourke K. Rationale, potentials, and promise of systematic reviews. In: Egger M, George DS, O'Rourke K, eds. Systematic Reviews in Health Care. London, United Kingdom: BMJ Publishing Group;2001:3\u201319","DOI":"10.1002\/9780470693926.ch1"},{"key":"2021120822525053400_R31","doi-asserted-by":"crossref","unstructured":"Johansen HK, Nir M, Hoiby N, Koch C, Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet.\u20081991;337:631\u2013634","DOI":"10.1016\/0140-6736(91)92449-C"},{"key":"2021120822525053400_R32","doi-asserted-by":"crossref","unstructured":"Mohon RT, Wagener JS, Abman SH, Seltzer WK, Accurso FJ. Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening. J Pediatr.\u20081993;122:550\u2013555","DOI":"10.1016\/S0022-3476(05)83534-6"},{"key":"2021120822525053400_R33","doi-asserted-by":"crossref","unstructured":"Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol.\u20081995;48:1041\u20131049","DOI":"10.1016\/0895-4356(94)00230-N"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/3\/888\/1073160\/zpe00906000888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/3\/888\/1073160\/zpe00906000888.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T08:27:22Z","timestamp":1707208042000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/3\/888\/69281\/Neonatal-Screening-for-Cystic-Fibrosis-Does-Not"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2599","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}